Zebularine suppresses TGF-beta-induced lens epithelial cell- myofibroblast transdifferentiation by inhibiting MeCP2

Molecular Vision

Volumn 17, Issue , 2011, Pages 2717-2723

  Zhou, Peng ^a   Lu, Yi ^a   Sun, Xing Huai ^a  

^a EYE AND ENT HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; METHYL CPG BINDING PROTEIN 2; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; ZEBULARINE;

ARTICLE; CAPSULE OPACIFICATION; CELL TRANSDIFFERENTIATION; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ACTINS; BLOTTING, WESTERN; CAPSULE OPACIFICATION; CATARACT EXTRACTION; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; CYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GENE EXPRESSION; GENE SILENCING; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MICROSCOPY, CONFOCAL; MYOFIBROBLASTS; POSTERIOR CAPSULE OF THE LENS; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA;

EID: 83055174009     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jiang YX, Lu Y, Liu TJ, Yang J, Chen Y, Fang YW. Using HSV-TK/GCV suicide gene therapy to inhibit lens epithelial cell proliferation for treatment of posterior capsular opacification. Mol Vis 2011; 17:291-9. [PMID: 21283526]
2. Awasthi N, Guo S, Wagner BJ. Posterior capsular opacification: a problem reduced but not yet eradicated. Arch Ophthalmol 2009; 127:555-62. [PMID: 19365040]
3. Chan E, Mahroo OA, Spalton DJ. Complications of cataract surgery. Clin Exp Optom 2010; 93:379-89. [PMID: 20735786]
4. Bhagwandien AC, Cheng YY, Wolfs RC, van Meurs JC, Luyten GP. Relationship between retinal detachment and biometry in 4262 cataractous eyes. Ophthalmology 2006; 113:643-9. [PMID: 16527355]
5. Konno K, Nagamoto T. Membranous proliferation on the posterior surface of an intraocular lens after Nd:YAG laser capsulotomy. Jpn J Ophthalmol 2005; 49:173-5. [PMID: 15838738]
6. Dawes LJ, Sleeman MA, Anderson IK, Reddan JR, Wormstone IM. TGFbeta/Smad4-dependent and-independent regulation of human lens epithelial cells. Invest Ophthalmol Vis Sci 2009; 50:5318-27. [PMID: 19516008]
7. Wormstone IM, Wang L, Liu CS. Posterior capsule opacification. Exp Eye Res 2009; 88:257-69. [PMID: 19013456]
8. Kim YS, Kim NH, Jung DH, Jang DS, Lee YM, Kim JM, Kim JSGenistein inhibits aldose reductase activity and high glucose-induced TGF-beta2 expression in human lens epithelial cells. Eur J Pharmacol20085941825 [PubMed: 18692043]
9. Yao K, Tan J, Ye P, Wang K, Xu W, ShenTu X, Tang X. Integrin beta1-mediated signaling is involved in transforming growth factor-beta2-promoted migration in human lens epithelial cells. Mol Vis 2007; 13:1769-76. [PMID: 17960115]
10. Hu B, Gharaee-Kermani M, Wu Z, Phan SH. Epigenetic regulation of myofibroblast differentiation by DNA methylation. Am J Pathol 2010; 177:21-8. [PMID: 20489138]
11. Hu B, Gharaee-Kermani M, Wu Z, Phan SH. Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis. Am J Pathol 2011; 178:1500-8. [PMID: 21435439]
12. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008; 320:1224-9. [PMID: 18511691]
13. Hurd PJ, Whitmarsh AJ, Baldwin GS, Kelly SM, Waltho JP, Price NC, Connolly BA, Hornby DP. Mechanism-based inhibition of C5-cytosine DNA methyltransferases by 2-H pyrimidinone. J Mol Biol 1999; 286:389-401. [PMID: 9973559]
14. Holleran JL, Parise RA, Joseph E, Eiseman JL, Covey JM, Glaze ER, Lyubimov AV, Chen YF, D'Argenio DZ, Egorin MJ. Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularine. Clin Cancer Res 2005; 11:3862-8. [PMID: 15897587]
15. Beumer JH, Eiseman JL, Parise RA, Joseph E, Holleran JL, Covey JM, Egorin MJ. Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine in mice. Clin Cancer Res 2006; 12:7483-91. [PMID: 17138702]
16. Cheng JC, Matsen CB, Gonzales FA, Ye W, Greer S, Marquez VE, Jones PA, Selker EU. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J Natl Cancer Inst 2003; 95:399-409. [PMID: 12618505]
17. Scott SA, Lakshimikuttysamma A, Sheridan DP, Sanche SE, Geyer CR, DeCoteau JF. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression. Exp Hematol 2007; 35:263-73. [PMID: 17258075]
18. Neureiter D, Zopf S, Leu T, Dietze O, Hauser-Kronberger C, Hahn EG, Herold C, Ocker M. Apoptosis, proliferation and differentiation patterns are influenced by Zebularine and SAHA in pancreatic cancer models. Scand J Gastroenterol 2007; 42:103-16. [PMID: 17190770]
19. He S, Kumar SR, Zhou P, Krasnoperov V, Ryan SJ, Gill PS, Hinton DR. Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro. Invest Ophthalmol Vis Sci 2010; 51:543-52. [PMID: 19696168]
20. Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, Bird A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 1992; 69:905-14. [PMID: 1606614]
21. Yasui DH, Peddada S, Bieda MC, Vallero RO, Hogart A, Nagarajan RP, Thatcher KN, Farnham PJ, Lasalle JM. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci USA 2007; 104:19416-21. [PMID: 18042715]
22. Mann J, Chu DC, Maxwell A, Oakley F, Zhu NL, Tsukamoto H, Mann DA. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 2010; 138:705-14. [PMID: 19843474]
23. Billam M, Sobolewski MD, Davidson NE. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells. Breast Cancer Res Treat 2010; 120:581-92. [PMID: 19459041]
24. Quintás-Cardama A, Tong W, Kantarjian H, Thomas D, Ravandi F, Kornblau S, Manshouri T, Cortes JE, Garcia-Manero G, Verstovsek S. A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis. Leukemia 2008; 22:965-70. [PMID: 18385750]
25. Braiteh F, Soriano AO, Garcia-Manero G, Hong D, Johnson MM, Silva Lde P, Yang H, Alexander S, Wolff J, Kurzrock R. Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers. Clin Cancer Res 2008; 14:6296-301. [PMID: 18829512]
26. Plummer R, Vidal L, Griffin M, Lesley M, de Bono J, Coulthard S, Sludden J, Siu LL, Chen EX, Oza AM, Reid GK, McLeod AR, Besterman JM, Lee C, Judson I, Calvert H, Boddy AV. Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors. Clin Cancer Res 2009; 15:3177-83. [PMID: 19383817]